Biblio

33557 resultats trouvés
A
Dubus M, Scomazzon L, Chevrier J, Ledouble C, Baldit A, Braux J, Gindraux F, Boulagnon C, Audonnet S, Colin M et al..  2022.  Antibacterial and Immunomodulatory Properties of Acellular Wharton's Jelly Matrix. BIOMEDICINES. 10:227.
Desroche N., Dropet C., Janod P., Guzzo J..  2016.  Antibacterial properties and reduction of MRSA biofilm with a dressing combining polyabsorbent fibres and a silver matrix. JOURNAL OF WOUND CARE. 25:577-584.
Valotteau C, Roelants SLKV, Dhasaiyan P, Zibek S, Guenther M, Soetaert W, Everaert B, Pradier C-M, Babonneau F, Baccile N et al..  2020.  Antibacterial properties of glycosylated surfaces: variation of the glucosidal moiety and fatty acid conformation of grafted microbial glycolipids. MOLECULAR SYSTEMS DESIGN & ENGINEERING. 5:1307-1316.
Dong Y, Xu Y, Li P, Wang C, Cao Y, Yu J.  2017.  Antibiofilm effect of ultrasound combined with microbubbles against Staphylococcus epidermidis biofilm. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY. 307:321-328.
Derosa L., C. Silva ACosta, Dalban C., Colomba E., Negrier S., Chevreau C.M, Gravis G., Oudard S.M, Laguerre B., Barthelemy P. et al..  2021.  Antibiotic (ATB) therapy and outcome from nivolumab (N) in metastatic renal cell carcinoma (mRCC) patients (pts): Results of the GETUG-AFU 26 NIVOREN multicentric phase II study. ANNALS OF ONCOLOGY. 32:S681.
Baudin F, Benzenine E, Mariet A-S, Bron AM, Daien V, Korobelnik J-F, Quantin C, Creuzot-Garcher C.  2019.  Antibiotic prophylaxis and intravitreal injections: impact on the incidence of acute endophthalmitis. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 60
Molina L, Udaondo Z, Duque E, Fernandez M, Molina-Santiago C, Roca A, Porcel M, de la Torre J, Segura A, Plesiat P et al..  2014.  Antibiotic Resistance Determinants in a Pseudomonas putida Strain Isolated from a Hospital. PLOS ONE. 9:e81604.
Castan B., Lesprit P., Alfandari S., Bonnet E., Diamantis S., Gauzit R., Kerneis S., Leroy J., Lescure X., Meyssonnier V. et al..  2017.  Antibiotic stewardship: A 2017 update. MEDECINE ET MALADIES INFECTIEUSES. 47:439-442.
Castan B., Lesprit P., Alfandari S., Bonnet E., Diamantis S., Gauzit R., Kerneis S., Leroy J., Lescure F.X, Mondain V. et al..  2016.  Antibiotic stewardship: What's new? MEDECINE ET MALADIES INFECTIEUSES. 46:403-405.
Feuillebois C., C. Salles B, H. Haore G, Vieux R., Chirouze C..  2020.  Antibiotic susceptibility of E. coli isolated from pediatric urine microscopy and culture tests: A 6-year study. MEDECINE ET MALADIES INFECTIEUSES. 50:302-304.
Bernard L, Dinh A, Ghout I, Simo D, Zeller V, Issartel B, Le Moing V, Belmatoug N, Lesprit P, Bru J-P et al..  2015.  Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial. LANCET. 385:875-882.
Kaderbhai C, Richard C, Fumet JDavid, Aarnink A, Foucher P, Coudert B, Favier L, Lagrange A, Limagne E, Boidot R et al..  2017.  Antibiotic Use Does Not Appear to Influence Response to Nivolumab. ANTICANCER RESEARCH. 37:3195-3200.
Collard M., Lakkis Z., Loriau J., Mege D., Sabbagh C., Lefevre J.H, Maggiori L..  2020.  Antibiotics alone as an alternative to appendectomy for uncomplicated acute appendicitis in adults: Changes in treatment modalities related to the COVID-19 health crisis. JOURNAL OF VISCERAL SURGERY. 157:S33-S42.
Coppry M., Jeanne-Leroyer C., Noize P., Dumartin C., Boyer A., Bertrand X., Dubois V., Rogues A-M..  2019.  Antibiotics associated with acquisition of carbapenem-resistant Pseudomonas aeruginosa in ICUs: a multicentre nested case-case-control study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 74:503-510.
Rabier M.BValnet, C. Slekovec B, Sahli S., Dautriche A., Davani S., Grandvuillemin A..  2017.  Antibiotic's real life profile and safety: a regional study. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 31:53.
Rabier M.BValnet, C. Slekovec B, Sahli S., Dautriche A., Davani S., Grandvuillemin A..  2017.  Antibiotic's real life profile and safety: a regional study. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 31:53.
Brembilla A., Mauny F., Garcia A., Koura K.G, Deloron P., Faucher J.-F.  2016.  Antibiotics usage in infants during the first 18 months of life in Benin: a population-based cohort study. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 35:681-689.
Brembilla A., Mauny F., Garcia A., Koura G.K, Deloron P., Faucher J.-F.  2015.  Antibiotics usage in infants during the first 18 months of life in a cohort study in Benin: the role of mothers and children's characteristics at birth and infants' clinical findings at consultations. TROPICAL MEDICINE & INTERNATIONAL HEALTH. 20:269.
Brembilla A., Mauny F., Garcia A., Koura G.K, Deloron P., Faucher J.-F.  2015.  Antibiotics usage in infants during the first 18 months of life in a cohort study in Benin: the role of mothers and children's characteristics at birth and infants' clinical findings at consultations. TROPICAL MEDICINE & INTERNATIONAL HEALTH. 20:269.
Billet L, Pesce S, Rouard N, Spor A, Paris L, Leremboure M, Mounier A, Besse-Hoggan P, Martin-Laurent F, Devers-Lamrani M.  2021.  Antibiotrophy: Key Function for Antibiotic-Resistant Bacteria to Colonize Soils-Case of Sulfamethazine-Degrading Microbacterium sp. C448. FRONTIERS IN MICROBIOLOGY. 12:643087.
Dubuisson A, Micheau O.  2017.  Antibodies and Derivatives Targeting DR4 and DR5 for Cancer Therapy. ANTIBODIES. 6:16.
Li L, Foo BJie Wei, Kwok KWai, Sakamoto N, Mukae H, Izumikawa K, Mandard S, Quenot J-P, Lagrost L, Teh WKeong et al..  2019.  Antibody Treatment against Angiopoietin-Like 4 Reduces Pulmonary Edema and Injury in Secondary Pneumococcal Pneumonia. MBIO. 10:e02469-18.
Rossi C, Chretien M-L, Casasnovas R-O.  2018.  Antibody-Drug Conjugates for the Treatment of Hematological Malignancies: A Comprehensive Review. TARGETED ONCOLOGY. 13:287-308.
Floch A, Morel A, Zanchetta-Balint F, Cordonnier-Jourdin C, Allali S, Grall M, Ithier G, Carpentier B, Pakdaman S, Merle J-C et al..  2020.  Anti-C5 antibody treatment for delayed hemolytic transfusion reactions in sickle cell disease. HAEMATOLOGICA. 105:2694-2697.
Lavaud P, Gravis G, Foulon S, Joly F, Oudard S, Priou F, Latorzeff I, Mourey L, Soulie M, Delva R et al..  2018.  Anticancer Activity and Tolerance of Treatments Received Beyond Progression in Men Treated Upfront with Androgen Deprivation Therapy With or Without Docetaxel for Metastatic Castration-naive Prostate Cancer in the GETUG-AFU 15 Phase 3 Trial. EUROPEAN UROLOGY. 73:696-703.

Pages